Clinical Trials
7 trialsNCT00264602 2025-11-10
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
Massachusetts General Hospital
Phase 1 Active not recruiting
NCT06121570 2023-11-08
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1 Recruiting
NCT02036918 2020-03-31
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
Duke University
Phase 1 Completed
NCT02968680 2020-03-30
Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma
University of Southern California
Phase 1 Terminated
NCT01121718 2017-02-03
NIR-Guided Sentinel Lymph Node Mapping in Melanoma
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00621452 2014-08-06
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
Phase 1 Completed
NCT00903214 2013-04-29
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn